Literature DB >> 12560785

Heart xenograft survival with chimeric pig donors and modest immune suppression.

William E Beschorner1, Debra L Sudan, Stanley J Radio, Tianyu Yang, Kenneth L Franco, Arthur C Hill, C Carson Shearon, Scott C Thompson, Robert S Dixon, Noel D Johnson, Charles A Kuszynski, Ronald J Rubocki, Kelly F Lechtenberg, Aurelio Matamoros, Timothy C Goertzen, Ira J Fox, Alan N Langnas.   

Abstract

OBJECTIVE: To assess the use of donor pigs with cellular chimerism for prevention of acute rejection with modest immune suppression. The clinical use of pig organ xenografts is currently precluded by severe acute rejection, which resists standard immune suppression. SUMMARY BACKGROUND DATA: For long-term survival of pig organ xenografts, immune suppression significantly greater than used with allografts would currently be necessary, leaving the recipient immune deficient and at increased risk for infections. Induction of immune tolerance and tissue accommodation could enhance xenograft survival but would lead to complications and frequent graft failure. Induction of cellular chimerism within the donor pigs, however, could accomplish these goals before transplantation, significantly reducing the risk.
METHODS: Marrow cells from sheep were infused into fetal pigs. Heart xenografts from chimeric or nonchimeric pigs were transplanted heterotopically into recipient sheep, simultaneous with infusion of splenocytes. Posttransplant suppression consisted of cyclosporine and tapered corticosteroids, comparable with allotransplants.
RESULTS: All of the control grafts (n = 12) were rejected by acute vascular rejection in 4 to 8 days. In contrast, only one episode of vascular rejection was observed in the experimental group (n = 13). Four experimental recipients had an episode of moderate diffuse cellular rejection (grade 3) and one had moderate focal cellular rejection (grade 2). Each episode responded to pulse steroids. Seven grafts showed no significant rejection. There was little evidence of immune deficiency, infection, or toxicity.
CONCLUSIONS: Acute vascular rejection was prevented in a large animal model without the need for severe immune suppression.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12560785      PMCID: PMC1522128          DOI: 10.1097/01.SLA.0000048456.81319.DA

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  29 in total

Review 1.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

Review 2.  Immunology of xenotransplantation.

Authors:  S Saadi; J L Platt
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

3.  Induction of human chimerism and functional suppressor cells in fetal pigs: feasibility of surrogate tolerogenesis for xenotransplantation.

Authors:  W E Beschorner; Z Qian; P Mattei; A D Hess; P M Colombani; A C Sciscione; A Khouzami; K J Blakemore; J F Burdick
Journal:  Transplant Proc       Date:  1996-04       Impact factor: 1.066

4.  Skin graft tolerance across a discordant xenogeneic barrier.

Authors:  Y Zhao; K Swenson; J J Sergio; J S Arn; D H Sachs; M Sykes
Journal:  Nat Med       Date:  1996-11       Impact factor: 53.440

Review 5.  Delayed xenograft rejection.

Authors:  W W Hancock
Journal:  World J Surg       Date:  1997 Nov-Dec       Impact factor: 3.352

Review 6.  Infectious concerns of cross-species transplantation: xenozoonoses.

Authors:  M G Michaels
Journal:  World J Surg       Date:  1997 Nov-Dec       Impact factor: 3.352

7.  Prolonged discordant cardiac xenograft survival in newborn recipients.

Authors:  H Xu; S R Gundry; A C Hill; C W Zuppan; T Morimoto; G Matsumiya; O Fagoaga; L L Bailey
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

8.  The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.

Authors:  S S Lin; B C Weidner; G W Byrne; L E Diamond; J H Lawson; C W Hoopes; L J Daniels; C W Daggett; W Parker; R C Harland; R D Davis; R R Bollinger; J S Logan; J L Platt
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

Review 9.  Tolerance induction for xenotransplantation.

Authors:  M Sykes; Y Zhao; Y G Yang
Journal:  World J Surg       Date:  1997 Nov-Dec       Impact factor: 3.352

10.  Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.

Authors:  Y G Yang; E deGoma; H Ohdan; J L Bracy; Y Xu; J Iacomini; A D Thall; M Sykes
Journal:  J Exp Med       Date:  1998-04-20       Impact factor: 14.307

View more
  4 in total

1.  Regenerative medicine for Parkinson's disease using differentiated nerve cells derived from human buccal fat pad stem cells.

Authors:  Haruka Takahashi; Hiroshi Ishikawa; Akira Tanaka
Journal:  Hum Cell       Date:  2017-02-16       Impact factor: 4.174

2.  Immunological and functional features of decellularized xenogeneic heart valves after transplantation into GGTA1-KO pigs.

Authors:  Robert Ramm; Tobias Goecke; Peter Köhler; Igor Tudorache; Serghei Cebotari; Anatol Ciubotaru; Samir Sarikouch; Klaus Höffler; Friederike Bothe; Björn Petersen; Axel Haverich; Heiner Niemann; Andres Hilfiker
Journal:  Regen Biomater       Date:  2021-08-03

3.  Transplantable liver production plan: "Yamaton"--liver project, Japan.

Authors:  Toshiyuki Hata; Shinji Uemoto; Eiji Kobayashi
Journal:  Organogenesis       Date:  2013-07-29       Impact factor: 2.500

4.  Assessment of fetal cell chimerism in transgenic pig lines generated by Sleeping beauty transposition.

Authors:  Wiebke Garrels; Stephanie Holler; Ulrike Taylor; Doris Herrmann; Heiner Niemann; Zoltan Ivics; Wilfried A Kues
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.